drugset / Trial / NCT07152288
Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study is being conducted to compare the pharmacokinetics, safety, and pharmacodynamics of HSK39297 in subjects with mild to moderate hepatic impairment and normal hepatic function
Timeline
- Start
- 2025-05-29
- Primary completion
- 2025-09
- Completion
- 2025-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK39297 | Unknown | — | Oral |